# Immersion Corp: overview IMMR · Nasdaq · CIK 1058811 · [Technology](/sectors/technology.md) · fiscal year ends Apr 30 Pages: [Overview](/companies/immr.md) · [Financials](/companies/immr/financials.md) · [Filings](/companies/immr/filings.md) · [Insiders](/companies/immr/insiders.md) Latest reported revenue: [$294.4m](/filings/0001193125-26-389919.md) for Q1 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-389919). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [616](/filings/0001193125-26-153417.md) | [471](/filings/0001193125-26-201951.md) | [285 d](/filings/0001193125-26-316089.md) | [292](/filings/0001193125-26-389919.md) | [650](/filings/0001193125-26-153417.md) | [518](/filings/0001193125-26-201951.md) | [270 d](/filings/0001193125-26-316089.md) | [294](/filings/0001193125-26-389919.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [11.4%](/filings/0001193125-26-153417.md) | [7.5%](/filings/0001193125-26-201951.md) | [(0.4%) d](/filings/0001193125-26-316089.md) | [(9.0%)](/filings/0001193125-26-389919.md) | [6.2%](/filings/0001193125-26-153417.md) | [1.0%](/filings/0001193125-26-201951.md) | [2.7% d](/filings/0001193125-26-316089.md) | [(6.8%)](/filings/0001193125-26-389919.md) | | Net margin | % | [5.0%](/filings/0001193125-26-153417.md) | [5.1%](/filings/0001193125-26-201951.md) | [(6.2%) d](/filings/0001193125-26-316089.md) | [(0.3%)](/filings/0001193125-26-389919.md) | [1.8%](/filings/0001193125-26-153417.md) | [(2.0%)](/filings/0001193125-26-201951.md) | [1.4% d](/filings/0001193125-26-316089.md) | [1.7%](/filings/0001193125-26-389919.md) | | Diluted EPS | $ per share | [0.93](/filings/0001193125-26-153417.md) | [0.73](/filings/0001193125-26-201951.md) | not reported | [(0.03)](/filings/0001193125-26-389919.md) | [0.36](/filings/0001193125-26-153417.md) | [(0.31)](/filings/0001193125-26-201951.md) | not reported | [0.17](/filings/0001193125-26-389919.md) | | Free cash flow | $m | [47.6 d](/filings/0001193125-26-153417.md) | [(46.2) d](/filings/0001193125-26-201951.md) | [47.0 d](/filings/0001193125-26-316089.md) | [(65.4)](/filings/0001193125-26-389919.md) | [66.3 d](/filings/0001193125-26-153417.md) | [(37.5) d](/filings/0001193125-26-201951.md) | [79.4 d](/filings/0001193125-26-316089.md) | [(47.1)](/filings/0001193125-26-389919.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2025 (2025-04-30) | FY2026 (2026-04-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [35.1](/filings/0001628280-23-004561.md) | [38.5](/filings/0001213900-24-021235.md) | [33.9](/filings/0001193125-26-102681.md) | [1,556](/filings/0001193125-26-316089.md) | [1,731](/filings/0001193125-26-316089.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [50.7%](/filings/0001628280-23-004561.md) | [63.5%](/filings/0001213900-24-021235.md) | [52.9%](/filings/0001193125-26-102681.md) | [7.6%](/filings/0001193125-26-316089.md) | [1.5%](/filings/0001193125-26-316089.md) | | Net margin | % | [35.6%](/filings/0001628280-23-004561.md) | [79.7%](/filings/0001213900-24-021235.md) | [100.2%](/filings/0001193125-26-102681.md) | [4.1%](/filings/0001193125-26-316089.md) | [0.3%](/filings/0001193125-26-316089.md) | | Diluted EPS | $ per share | [0.39](/filings/0001628280-23-004561.md) | [0.92](/filings/0001213900-24-021235.md) | [1.04](/filings/0001193125-26-102681.md) | [1.90](/filings/0001193125-26-316089.md) | [0.14](/filings/0001193125-26-316089.md) | | Free cash flow | $m | [17.1](/filings/0001628280-23-004561.md) | [40.1](/filings/0001213900-24-021235.md) | [20.6](/filings/0001193125-26-102681.md) | [(68.8)](/filings/0001193125-26-316089.md) | [42.9](/filings/0001193125-26-316089.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/immr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $16.5m | 2,441,162 | | Added +151,145 | | [CDC Financial, Inc.](/funds/2077836.md) | 2026-06-30 | $8.8m | 1,293,007 | | Reduced −144,390 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.7m | 1,287,153 | | Reduced −1,116 | | [Kanen Wealth Management LLC](/funds/1681614.md) | 2026-06-30 | $7.0m | 1,013,700 | | Added +304,700 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $6.6m | 971,600 | Put | Added +239,900 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.1m | 760,348 | | Added +24,851 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.4m | 644,798 | | Reduced −12,630 | | [Caption Management, LLC](/funds/1706766.md) | 2026-06-30 | $4.3m | 630,000 | Put | Reduced −198,300 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $4.1m | 611,074 | | Added +209,671 | | [NISSAY ASSET MANAGEMENT CORP /JAPAN](/funds/869589.md) | 2026-06-30 | $4.0m | 592,280 | | Reduced −15,088 | ## Recent filings [All 1,050 filings](/companies/immr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-07 | 20:10 ET | [8-K](/filings/0001193125-26-416964.md) | 5.07 Shareholder vote results | 0001193125-26-416964 | | 2026-09-14 | 13:06 ET | [10-Q](/filings/0001193125-26-389919.md) | Quarterly report, period 2026-07-31 | 0001193125-26-389919 | | 2026-09-14 | 13:03 ET | [8-K](/filings/0001193125-26-389915.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389915 | | 2026-08-28 | 20:02 ET | [DEF 14A](/filings/0001193125-26-374299.md) | Proxy statement, period 2026-08-28 | 0001193125-26-374299 | | 2026-08-21 | 23:42 ET | [SCHEDULE 13D](/filings/0000921895-26-002269.md) | Ownership report, active investor | 0000921895-26-002269 | | 2026-07-27 | 12:38 ET | [8-K](/filings/0001193125-26-316971.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-316971 | | 2026-07-24 | 20:11 ET | [10-K](/filings/0001193125-26-316089.md) | Annual report, period 2026-04-30 | 0001193125-26-316089 | | 2026-07-02 | 20:08 ET | [8-K](/filings/0001193125-26-294505.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-294505 | | 2026-05-15 | 12:25 ET | [8-K](/filings/0001193125-26-225412.md) | 8.01 Other events | 0001193125-26-225412 | | 2026-05-04 | 23:59 ET | [10-Q](/filings/0001193125-26-201951.md) | Quarterly report, period 2026-01-31 | 0001193125-26-201951 | ## Latest annual report [Form 10-K for the fiscal year ended Apr 30, 2026](/filings/0001193125-26-316089.md), filed Jul 24, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1058811 - Tickers: IMMR - Exchange: Nasdaq - SIC code: 3577 Computer Peripheral Equipment, NEC - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.